Home2019-10-24T02:03:26+00:00

Our mission is to improve the quality of life for those affected by sickle cell disease by promoting advocacy, education, research and excellent healthcare delivery.

Finding a Cure Together

NIH Launches New Collaboration to Develop Gene-based Cures for Sickle Cell Disease and HIV on Global Scale

The National Institutes of Health plans to invest at least $100 million over the next four years toward an audacious goal: develop affordable, gene-based cures for sickle cell disease (SCD) and HIV. The Bill & Melinda Gates Foundation will also invest $100 million toward this goal. The intention is for these cures to be made globally available, including in low-resource settings.

This initiative follows a bold announcement made earlier this year by President Donald J. Trump during the State of the Union Address to end the HIV epidemic in the United States in the next 10 years. Ending the HIV Epidemic: A Plan for America aims to leverage the powerful data and tools now available to reduce new HIV diagnoses in the United States by 75% in five years and by 90% by 2030. The Trump Administration has also elevated the attention paid to sickle cell disease, identifying it as an intractable health challenge with the potential for dramatic advances in the coming years.

MSCDA News & Events

NIH/Gates Foundation Collaboration to Develop Accessible, Gene-Based Cures for Sickle Cell Disease and HIV

October 24th, 2019|

Initial investment aims to advance accessible and scalable candidate interventions into clinical trials within 10 years. The collaboration will align aggressive, high-reward research efforts to accelerate progress on shared gene-based strategies (depicted in green) to [...]

To learn more about our services and how we can help, get in touch with us today.

Get in Touch Now

Your donations count! Donate to MSCDA today – let’s work together to find a cure.

Donate Now